Digital Outreach Intervention for Lung Cancer Screening
mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic randomized-controlled trial conducted with primary care patients in two large health networks, 2) Elucidate the drivers of patients' screening decisions and screening behavior; and 3) Explore implementation outcomes that will impact the sustainability and dissemination of mPATH-Lung using program data, surveys, and interviews. This project will determine how mPATH-Lung affects patients' screening decisions and their completion of screening.
Checked against the public recordLast updated Jun 25, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Screening
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Wake Forest University Health Sciences
- Interventions being studied
- Other: mPATH-Lung; Other: Lung health video
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Meet the Medicare criteria for lung cancer screening, as updated in February 2022: * Age 50 - 77 years * Smoked at least 20 pack years * Current smoker or quit smoking within the past 15 years * Be scheduled to see a primary care provider within the health network in the next 3-4 weeks * Have a patient portal account or cellphone number listed in the electronic health record Exclusion Criteria: * Patients flagged as needing a language interpreter in the electronic health record (electronic messages and intervention is delivered in English only). * Those for whom lung cancer screening would be inappropriate: * Prior history of lung cancer * Chest CT within the last 12 months * Those with medical conditions predicting shorter life expectancy * Patients whose home address is not within the state of North Carolina. (Due to telehealth guidelines)
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of North Carolina- Chapel HillChapel Hill, North Carolina
- Wake Forest Baptist Medical CenterWinston-Salem, North Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 25, 2025. Always confirm current availability with the study team.